Ekong, Almuid A.
HRN: 22-75-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/15/2023
03/21/2023
IV
600mg
Q6
Open Fracture
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes